EUVIMEDEUVIMED entdecken
Crossref

Healthcare Systems and Artificial Intelligence: Focus on Challenges and the International Regulatory Framework

Alessia Romagnoli, Francesco Ferrara, Roberto Langella, Andrea Zovi

Pharmaceutical Research · 2024-04 · 41 (4) · 721-730

DOI: 10.1007/s11095-024-03685-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Research, online erschienen am 05.03.2024. Verfasst von Alessia Romagnoli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Territorial Pharmaceutical Service, Local Health Unit Lanciano Vasto Chieti, Chieti, Italy. Hauptthemen laut MEDLINE: Artificial Intelligence, Algorithms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Nowadays, healthcare systems are coping with the challenge of countering the exponential growth of healthcare costs worldwide, to support sustainability and to guarantee access to treatment for all patients. METHODS: Artificial Intelligence (AI) is the technology able to perform human cognitive functions through the creation of algorithms. The value of AI in healthcare and its ability to address healthcare delivery issues has been a subject of discussion within the scientific community for several years. RESULTS: The aim of this work is to provide an overview of the primary uses of AI in the healthcare system, to discuss its desirable future uses while shedding light on the major issues related to implications within international regulatory processes. In this manuscript, it will be described the main applications of AI in various aspects of health care, from clinical studies to ethical implications, focusing on the international regulatory framework in countries in which AI is used, to discuss and compare strengthens and weaknesses. CONCLUSIONS: The challenges in regulatory processes to facilitate the integration of AI in healthcare are significant. However, overcoming them is essential to ensure that AI-based technologies are adopted safely and effectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceAlgorithmsHumansCoping SkillsDelivery of Health Care

Stichwörter der Autor:innen

AIartificial intelligencehealthcaretherapeutic treatment regulatory framework

Autor:innen und Institutionen

  • Territorial Pharmaceutical Service, Local Health Unit Lanciano Vasto Chieti, Chieti, Italy.
  • Pharmaceutical Department, Asl Napoli 3 Sud, Dell'amicizia street 22, 80035, Nola, Naples, Italy. f.ferrara@aslnapoli3sud.it.
  • Italian Society of Hospital Pharmacy (SIFO), SIFO Secretariat of the Lombardy Region, Carlo Farini street, 81, 20159, Milan, Italy.
  • Ministry of Health, Viale Giorgio Ribotta 5, 00144, Rome, Italy.

Zitieren

APA

Romagnoli, A., Ferrara, F., Langella, R., & Zovi, A. (2024). Healthcare Systems and Artificial Intelligence: Focus on Challenges and the International Regulatory Framework. Pharmaceutical Research, 41(4), 721-730. https://doi.org/10.1007/s11095-024-03685-3

Vancouver

Romagnoli A, Ferrara F, Langella R, Zovi A. Healthcare Systems and Artificial Intelligence: Focus on Challenges and the International Regulatory Framework. Pharmaceutical Research. 2024;41(4):721-730. doi:10.1007/s11095-024-03685-3

BibTeX
@article{Romagnoli2024,
  author = {Romagnoli, Alessia and Ferrara, Francesco and Langella, Roberto and Zovi, Andrea},
  title = {Healthcare Systems and Artificial Intelligence: Focus on Challenges and the International Regulatory Framework},
  journal = {Pharmaceutical Research},
  year = {2024},
  volume = {41},
  number = {4},
  pages = {721--730},
  doi = {10.1007/s11095-024-03685-3}
}
Kostenlos starten →